Cheng A - Search Results

1

Feasibility and considerations of epsin2 as a candidate target for multiple system atrophy treatment.

Cheng A, Cai B, Fukunaga K, Sasaki T, Lakkaraju A. Cheng A, et al. Expert Opin Ther Targets. 2023 Jul-Dec;27(11):1031-1034. doi: 10.1080/14728222.2023.2277227. Epub 2023 Dec 7. Expert Opin Ther Targets. 2023. PMID: 37902421 No abstract available.

2

Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation.

Cheng A, Kawahata I, Wang Y, Jia W, Wang H, Sekimori T, Chen Y, Suzuki H, Takeda A, Stefanova N, Finkelstein DI, Ma W, Chen M, Sasaki T, Fukunaga K. Cheng A, et al. Brain. 2023 Aug 1;146(8):3172-3180. doi: 10.1093/brain/awad137. Brain. 2023. PMID: 37082980

3

Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model.

Cheng A, Jia W, Finkelstein DI, Stefanova N, Wang H, Sasaki T, Kawahata I, Fukunaga K. Cheng A, et al. Acta Pharmacol Sin. 2024 Jan;45(1):66-75. doi: 10.1038/s41401-023-01138-y. Epub 2023 Aug 21. Acta Pharmacol Sin. 2024. PMID: 37605049 Free PMC article.

4

[Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies].

Cheng A, Fukunaga K. Cheng A, et al. Nihon Yakurigaku Zasshi. 2022;157(6):396-400. doi: 10.1254/fpj.22056. Nihon Yakurigaku Zasshi. 2022. PMID: 36328545 Japanese.

5

Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor.

Jia W, Kawahata I, Cheng A, Sasaki T, Sasaoka T, Fukunaga K. Jia W, et al. Among authors: cheng a. Int J Mol Sci. 2023 Apr 2;24(7):6644. doi: 10.3390/ijms24076644. Int J Mol Sci. 2023. PMID: 37047614 Free PMC article.

6

Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes.

Cheng A, Kawahata I, Fukunaga K. Cheng A, et al. Biomedicines. 2020 Dec 20;8(12):635. doi: 10.3390/biomedicines8120635. Biomedicines. 2020. PMID: 33419250 Free PMC article.

7

The Role of CaMKII and ERK Signaling in Addiction.

Jia W, Kawahata I, Cheng A, Fukunaga K. Jia W, et al. Among authors: cheng a. Int J Mol Sci. 2021 Mar 20;22(6):3189. doi: 10.3390/ijms22063189. Int J Mol Sci. 2021. PMID: 33804804 Free PMC article. Review.

8

A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models.

Cheng A, Jia W, Kawahata I, Fukunaga K. Cheng A, et al. EBioMedicine. 2021 Oct;72:103582. doi: 10.1016/j.ebiom.2021.103582. Epub 2021 Oct 5. EBioMedicine. 2021. PMID: 34624687 Free PMC article.

9

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy.

Cheng A, Jia W, Kawahata I, Fukunaga K. Cheng A, et al. Biomedicines. 2021 May 17;9(5):560. doi: 10.3390/biomedicines9050560. Biomedicines. 2021. PMID: 34067791 Free PMC article. Review.

10

Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization.

Cheng A, Shinoda Y, Yamamoto T, Miyachi H, Fukunaga K. Cheng A, et al. Brain Res. 2019 Mar 15;1707:190-197. doi: 10.1016/j.brainres.2018.11.036. Epub 2018 Nov 26. Brain Res. 2019. PMID: 30496735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,063 results

Search Page

Filters